文献速递慢性肾脏病

年轻和中年成人冠状动脉钙化与慢性肾脏病风险

Coronary artery calcium and risk of chronic kidney disease in young and middle-aged adults.
PubMed 文献 · Nephrol Dial Transplant · 2023-01-01

在113171名无慢性肾脏病和蛋白尿的韩国成人(平均年龄40.6岁)中开展队列研究,中位随访4.2年。冠状动脉钙化评分越高,慢性肾脏病风险呈剂量依赖性升高,即使低评分也相关。冠状动脉钙化评分>0者风险增加,可能从预防措施中获益。

要点

  • 冠状动脉钙化评分1-100、101-300和>300者慢性肾脏病风险均高于评分为0者。
  • 以估算肾小球滤过率降低定义时,评分101-300的风险比95%置信区间跨1,未达统计学显著。
  • 以蛋白尿定义时,各评分组风险比均升高且趋势检验有统计学意义。

核心结论

  • 冠状动脉钙化评分越高,慢性肾脏病风险呈剂量依赖性升高,即使低评分也相关;评分>0的个体风险增加,可能从预防措施中获益。

研究设计与样本

  • 队列研究,纳入113171名基线无慢性肾脏病和蛋白尿的韩国成人(平均年龄40.6岁),均接受心脏断层扫描评估冠状动脉钙化评分,中位随访4.2年。

主要发现

  • 与冠状动脉钙化评分为0相比,评分1-100、101-300和>300者慢性肾脏病的多变量校正风险比分别为1.15(95%置信区间1.05-1.25)、1.37(95%置信区间1.13-1.66)和1.71(95%置信区间1.32-2.22),趋势检验P<.001。
  • 以估算肾小球滤过率<60 ml/min/1.73 m2定义时,评分1-100、101-300和>300者风险比分别为1.31(95%置信区间1.05-1.62)、1.41(95%置信区间0.95-2.11)和1.86(95%置信区间1.16-3.00),趋势检验P=.001。
  • 以蛋白尿定义时,评分1-100、101-300和>300者风险比分别为1.11(95%置信区间1.02-1.21)、1.32(95%置信区间1.07-1.64)和1.57(95%置信区间1.16-2.12)。

临床怎么用

  • 作者认为,冠状动脉钙化评分>0的个体慢性肾脏病风险增加,可能从降低慢性肾脏病风险的预防措施中获益。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The role of the coronary artery calcium score (CACS) in incident chronic kidney disease (CKD) in asymptomatic young populations remains unclear. The aim of this study was to evaluate the association between CACSs and CKD development in adults. METHODS: A cohort study of 113 171 Korean adults (mean age 40.6 years) without CKD and proteinuria at baseline who underwent a cardiac tomography estimation of CACSs during health screening examinations was performed (median follow-up 4.2 years). The outcome was CKD, defined as an estimated glomerular filtration rate (eGFR) <60 ml/min/1.73 m2 and/or the presence of proteinuria. Hazard ratios (HRs) and 95% confidence intervals (CIs) for CKD were estimated using Cox proportional hazards regression analyses. RESULTS: A higher CACS was moderately associated with an increased risk of CKD in a dose-dependent manner. The multivariable-adjusted HRs for CKD comparing CACSs 1-100, 101-300 and >300 with a CACS of 0 were 1.15 (95% CI 1.05-1.25), 1.37 (95% CI 1.13-1.66) and 1.71 (95% CI 1.32-2.22), respectively (P for trend <.001). When CKD was defined using low eGFR and proteinuria separately, corresponding HRs for low eGFR were 1.31 (95% CI 1.05-1.62), 1.41 (95% CI 0.95-2.11) and 1.86 (95% CI 1.16-3.00), respectively (P for trend = .001), while the HRs for proteinuria were 1.11 (95% CI 1.02-1.21), 1.32 (95% CI 1.07-1.64) and 1.57 (95% CI 1.16-2.12), respectively. CONCLUSIONS: A higher CACS was progressively associated with an increased risk of CKD, even at low CACSs. Individuals with a CACS >0 appear to have an increased risk of CKD and may benefit from preventive measures to reduce CKD risk.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Kim Y, Kang J, Chang Y, et al. Coronary artery calcium and risk of chronic kidney disease in young and middle-aged adults. Nephrol Dial Transplant. 2023. PMID: 36107450. doi:10.1093/ndt/gfac272

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。